VLP-Polio
Phase 1Biologic
CanSino Biologics Inc.VLP-Polio is one of 10 biologic programs targeting Poliomyelitis. It is currently in Phase 1.
1
Indications
2
Total Trials
1
Active Trials
9
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
30 competitors in Poliomyelitis
#DrugCompanyPhaseTrials
1Comparator: Pbo
Merck & Co.Phase 3
Rotateq
Merck & Co.Phase 3
Hepatitis B Vaccine
SanofiPhase 2
Inactivated Rabies Virus Vaccine
SanofiPhase 2
Sipv
Sinovac Biotech Co., LtdApproved
Concomitant Administration
SanofiPhase 3
Oral NVB Metronomic
SanofiPhase 2
Verazinc
FFakultas Kedokteran Universitas Indonesia
Preclinical
Poliorix.
GSKPhase 1
VLP-Polio
CanSino Biologics Inc.Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for VLP-Polio. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Phase 1[1]
- Company